Crossmark

Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia

Published Online: 2021-04-01

Published Print: 2021-12

Authors

Uusküla, Anneli https://orcid.org/0000-0002-4036-3856
Talu, Ave

Rannap, Jürgen

Barnes, David M.

Jarlais, Don Des
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (1DP1DA039542)

Estonian Ministry of Education and Research (IUT34-17)
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-01
More Information

Article History

Received: 4 September 2020

Accepted: 22 March 2021

First Online: 1 April 2021

Declarations

:

: Ethical approval for the study was obtained from the Ethics Review Board of the University of Tartu, Estonia and from the Mount Sinai Beth Israel Medical Center Institutional Review Board in New York City, NY, USA. Written informed consent was secured from all participants.

: NA.

: The authors report no conflicts of interest.

Document is current